RadDefense 2 (raddefense2) NDC 64616-117

NDC codes

FDA NDC Directory

Product NDC (as listed)64616-117Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64616-0117Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64616-117-02	64616011702	1 BOTTLE, DROPPER in 1 CARTON (64616-117-02) / 30 mL in 1 BOTTLE, DROPPER (64616-117-01)Marketed from Mar 2, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): RadDefense 2
Generic name (nonproprietary): raddefense2
Active ingredients: Rheum palmatum root — 30 [hp_C]/.03mLCalifornium cf-249 — 30 [hp_C]/.03mLEupatorium perfoliatum flowering top — 30 [hp_C]/.03mL
Dosage form: Liquid
Route: Oral
Labeler: Vitality Works, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 24, 2016
Listing expires: Dec 31, 2026
Identifiers: Product ID 64616-117_462f67c6-2b7e-f323-e063-6394a90a4ca5SPL ID 462f67c6-2b7e-f323-e063-6394a90a4ca5SPL set ID 2d796691-adc5-52b3-e054-00144ff8d46cUNII G025DAL7CE, R08357L1XX, 1W0775VX6E

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464616011702 followed by a unit qualifier and the quantity

Package 64616-0117-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025.

Indications (excerpt from the label)

Uses Since Fukushima, you may have noticed one or more of the following: headaches, joint aches, bone aches, muscle aches, lung complications (e.g. ongoing cough, respiratory irritation). digestive problems, vision weakness.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)